/

RadioMedix

Develops targeted radiopharmaceuticals for cancer diagnosis and treatment

BiotechnologyPharmaceuticals radiomedix.com ↗

Company facts

Founded: 2006
Employees: 40
Headquarters: United States
Type: Private
Funding: Series A · $40M · 2022
Subsidiaries: Detectnet, AlphaMedix, GlucoMedix, OncoMedix, SmartMedix